Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended vs Interrupted Oral Contraceptives for Menstrually-Related Mood Disorders
NCT00089414Phase 2Terminated
- Sponsor
- National Institute of Mental Health
- Start
- Jul 2004
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinyl estradiol + drospirenone in Premenstrual Dysphoric Disorder (PMDD), premenstrual syndrome (PMS), sponsored by National Institute of Mental Health. Started Jul 2004; status: terminated.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT00089414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089414.